Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
07/1997
07/31/1997WO1997027220A2 Substrates and inhibitors for cysteine protease ich-1
07/31/1997WO1997027213A1 Methods for screening for transdominant effector peptides and rna molecules
07/31/1997WO1997027212A1 Methods for screening for transdominant intracellular effector peptides and rna molecules
07/31/1997WO1997026986A1 Device and process for the synthetization of macromolecules
07/31/1997WO1997026920A2 Conjugate for differentiating between diseased and healthy tissues
07/31/1997WO1996040772A3 Agonist peptide dimers
07/31/1997DE19602464A1 Apparatus for multiple, simultaneous and parallel synthesis of chemicals
07/31/1997CA2244222A1 Methods for screening for transdominant effector peptides and rna molecules
07/31/1997CA2243497A1 Substrates and inhibitors for cysteine protease ich-1
07/30/1997EP0786521A1 Nucleic acid encoding PspA
07/30/1997EP0786520A1 Method for the production of biological active beta-NGF by genetic engineering
07/30/1997EP0786473A2 Basic protein composition, basic peptide composition and application thereof
07/30/1997EP0786085A1 Method and apparatus for efficient mimotope discovery
07/30/1997EP0786009A1 Process for bacterial production of heterologous polypeptides with disulphide bonds
07/30/1997EP0785951A1 Tc or re radiolabelled somatostatin analogs
07/30/1997EP0785949A1 Method for purifying keratinocyte growth factors
07/30/1997EP0785920A1 Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates
07/30/1997EP0785799A1 Process for production of inhibited forms of activated blood factors
07/30/1997EP0703825B1 Method and apparatus for conducting an array of chemical reactions on a support surface
07/30/1997EP0476044B1 Use of IGF1 or IGF2 for the manufacture of a medicament in the treatment of amyotrophic lateral sclerosis
07/30/1997CN1155550A Preparation of specificity antivirus factor from yolks
07/30/1997CN1155549A Non-densatured extraction of medical collagen protein and denatured application
07/29/1997US5652348 Solid support matrix, ionizable ligands selected relative to target compound
07/29/1997US5652342 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
07/29/1997US5652339 Method of producing reconstituted lipoproteins
07/29/1997US5652336 Peptide synthesis
07/29/1997US5652235 Method of using spiro piperidines to promote the release of growth hormone
07/29/1997US5652217 Nucleotide sequence from staphylococcus aureus which codes for protein or polypeptide
07/29/1997US5652213 Cyclic peptide antifungal agents
07/29/1997US5652112 Assay for type I collagen carboxy-terminal telopeptide analytes
07/29/1997US5651963 Heterodimers forms of CSF-1 and pharmaceutical compositions thereof
07/29/1997US5651943 Apparatus and method for random polymer synthesis
07/29/1997CA1339189C Amblyommin, a new active substance for anticoagulant therapy
07/29/1997CA1339188C Removal of protein a from antibody preparations
07/29/1997CA1339186C Process for reducing the aggregate content of growth hormone-like materials
07/29/1997CA1339106C Hirullin polypeptides having anticoagulant activity
07/29/1997CA1339104C Hirudin derivative
07/26/1997CA2195727A1 Process for extending the assay range and for avoiding the hook effect in simultaneous sandwich immunoassays, and corresponding test kits
07/24/1997WO1997026359A1 System for the expression of heterologous antigens as fusion proteins
07/24/1997WO1997026277A2 Morphogen analogs and methods for producing them
07/24/1997WO1997026275A1 Protein occlusion for delivery of small molecules
07/24/1997WO1997026002A1 Synthesis of conformationally restricted amino acids, peptides and peptidomimetics by catalytic ring closing metathesis
07/24/1997WO1997021993A3 Nuclear receptor ligands and ligand binding domains
07/24/1997DE19602295A1 Konjugat zur Unterscheidung von krankhaftem und gesundem Gewebe Conjugate to distinguish between diseased and healthy tissue
07/24/1997CA2244228A1 Morphogen analogs and methods for producing them
07/24/1997CA2214840A1 System for the expression of heterologous antigens as fusion proteins
07/23/1997EP0785213A1 Peptide ligands which bind to von Willebrand factor
07/23/1997EP0784980A1 Collagen hydrolysis accelerator
07/23/1997EP0784676A1 Neutralization of foof allergens by thioredoxin
07/23/1997EP0784632A1 Process for extracting high-purity von willebrand factor
07/23/1997EP0784469A1 Compositions for the delivery of antigens
07/23/1997EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
07/22/1997US5650496 Efficient purification of insulin-like growth factor i
07/22/1997US5650495 Protein having an affinity for a heparin-binding growth factor
07/22/1997US5650494 Process for refolding recombinantly produced TGF-β-like proteins
07/22/1997US5650492 P-40 homodimer of interleukin-12
07/22/1997US5650489 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
07/22/1997US5650393 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
07/22/1997US5650311 Doped sol-gel glasses for obtaining chemical interactions
07/22/1997US5650300 Method of producing monoclonal antibodies to oncofetal protein
07/22/1997US5650292 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
07/22/1997US5650234 For use as membrane coatings
07/22/1997US5650055 Electrophoresis separation method and apparatus using barrier separation and polarity reversing
07/17/1997WO1997025352A1 PROCESS FOR ISOLATING IgG AND IgA
07/17/1997WO1997025342A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione
07/17/1997CA2242778A1 Process for isolating igg and iga
07/16/1997EP0784093A1 Osteoprotegerin
07/16/1997EP0783519A1 New peptides with immunomodulatory effects
07/16/1997EP0783516A1 Phosphorus-32 labeling of antibodies for cancer therapy
07/16/1997EP0783515A2 Protective and linking groups and their use (carbamides)
07/16/1997EP0783366A1 Chromatographic resins and methods for using same
07/16/1997EP0783326A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
07/16/1997EP0783316A1 Synthetic antibiotics
07/16/1997EP0783299A1 Compounds and compositions for delivering active agents
07/16/1997EP0586618B1 The use of nucleic acid analogues in diagnostics and analytical procedures
07/15/1997US5648472 Process for preparing virus-inactivated immunoglobulin solutions
07/15/1997US5648467 Human cytokine
07/15/1997US5648462 Peptide purification method using novel linker and solid-phase ligand
07/15/1997US5648456 Reductive cleavage with borohydride
07/15/1997US5648272 Reagents and methods for the detection and quantification of thyroxine in fluid samples
07/15/1997US5648242 Method of production of birch pollen allergen P14
07/15/1997US5648080 Antigenic preparations and isolation of such preparations
07/15/1997US5648072 Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor
07/10/1997WO1997024301A1 Preparation method of physiologically active compound
07/10/1997WO1997020855A3 Solid phase organic synthesis
07/10/1997WO1997017451A3 Production of gad65 in methylotrophic yeast
07/10/1997WO1997017450A3 Compositions and methods for producing heterologous polypeptides in pichia methanolica
07/09/1997EP0783002A2 Dual action inhibitors
07/09/1997CN1153784A Biotin derivatives
07/08/1997US5646302 Heterotrifunctional compounds for photoaffinity labelling
07/08/1997US5646301 Incorporation into peptides
07/08/1997US5646285 Orthogonally protected compounds
07/08/1997US5646245 Process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
07/08/1997US5646242 Amidation of insulin or derivative with soluble, activated fatty acid ester; one step
07/08/1997US5646121 Pseudopeptides with antiviral activity
07/08/1997US5646110 Cyclic peptides
07/08/1997US5646017 Methods of generating desired amino-terminal residues in proteins
07/08/1997US5645838 Antigen
07/03/1997WO1997023615A1 Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof
07/03/1997WO1997023499A1 Prodrugs of thrombin inhibitors